Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies have?
Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies has 140 citations in the OpenAlex counts ScholarIQ stores.
When was Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies published?
Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies has 2023 year in the ScholarIQ index.
What is the open-access status of Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies?
Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies has gold oa status in the ScholarIQ index.
What is the DOI of Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies?
The DOI for Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies is on the source record.
What is the PMID of Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies?
The PMID for Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies is on the source record.
What is the OpenAlex record for Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies?
The OpenAlex for Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies is on the source record.